Mitigating the Mitochondrial Dysfunction and Apoptosis in Hypertrophied Left Atrium of Patients With Severe Mitral Valve Regurgitation Via Short-term Lovaza Treatment Prior to Surgery.

Trial Profile

Mitigating the Mitochondrial Dysfunction and Apoptosis in Hypertrophied Left Atrium of Patients With Severe Mitral Valve Regurgitation Via Short-term Lovaza Treatment Prior to Surgery.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Sep 2013

At a glance

  • Drugs Omega-3-acid ethyl esters (Primary)
  • Indications Mitral valve disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 09 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 21 Jun 2011 Planned end date changed from 1 Dec 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 19 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top